HEALTH PROFESSIONAL · SOURCE READING

Supportive care

Source: Childhood Acute Myeloid Leukemia Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: April 15, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.

Context: Treatment of Childhood AML / Induction Therapy

In children with AML receiving modern intensive therapy, the estimated incidence of severe bacterial infections is 50% to 60%, and the estimated incidence of invasive fungal infections is 7.0% to 12.5%.[32-34] Several approaches have been examined to reduce the morbidity and mortality from infection in children with AML.

Source links and citations

Continue within this section

Antimicrobial prophylaxis →Antifungal prophylaxis →Hematopoietic growth factors →Cardiac monitoring →Hospitalization →

Publication references

Read the original reference and check its publication notices.

Preserved source evidence · Not medical advice